1.Advances in lactic acid bacteria as recombinant protein drug delivery carrier
Xufang WANG ; Yanting WANG ; Chunmeng YAO ; Bin LU
Journal of Pharmaceutical Practice and Service 2026;44(1):7-11
Lactic acid bacteria (LAB) are promising candidates for live bacterial drug delivery systems owing to their safety, probiotic properties, and ability to colonize the intestinal tract. At present, most research focuses on engineering LAB as carriers for the delivery of therapeutic proteins. As model organisms equipped with a versatile set of genetic tools, LAB can be readily modified to target various diseases and yield significant therapeutic effects. LAB-based carriers offer multiple advantages, including non-invasive delivery, ease of genetic manipulation, and suitability for large-scale production. Consequently, the use of LAB as recombinant protein expression vectors has attracted extensive research interest worldwide. The foundational principles, strategies for enhancing bioavailability, genetic engineering approaches, and the current research and application status of LAB-based drug delivery systems were summarized in this paper.
2.Celecoxib inhibits thrombin-induced chondrocyte degeneration in rats
Zhiheng ZHU ; Jiaying DING ; Yangshuo GE ; Chunmeng HUANG ; Jun SHEN ; Xuezong WANG ; Yuxin ZHENG ; Daofang DING
Chinese Journal of Tissue Engineering Research 2024;28(34):5446-5451
BACKGROUND:The content of serum thrombin in patients with osteoarthritis is significantly higher than that in normal individuals,and thrombin can induce inflammatory degeneration of rat chondrocytes,suggesting that inhibiting the function of thrombin may become a method for treating osteoarthritis.Celecoxib is a common therapeutic drug for the clinical treatment of osteoarthritis.It is not yet known whether it improves chondrocyte degeneration by inhibiting the activity of thrombin. OBJECTIVE:To investigate the effect of celecoxib on thrombin-induced degeneration of rat chondrocytes. METHODS:Thrombin levels in the serum of osteoarthritis patients and normal individuals were detected by an ELISA kit.Primary chondrocytes of neonatal Sprague-Dawley rats were isolated,and all experiments were performed with cells from passage one.Chondrocytes were randomly divided into three groups:control group,thrombin group,and celecoxib group.The cell morphology of the three groups was observed under an inverted microscope,and an Edu kit was used to detect the cell proliferation.qRT-PCR was used to detect the expression of extracellular matrix components(aggrecan,elastin,cartilage oligomeric matrix proteins),inflammatory factors(interleukin-1,interleukin-6,and tumor necrosis factor-α),and chemokines(monocyte chemotactic protein 2,monocyte chemotactic protein 7,granulocyte chemotactic protein 6).The expression of type 2 collagen α1 was detected by immunofluorescence.Western blot method was used to detect the expression of catabolic metabolism genes,such as matrix metalloproteinase 9,matrix metalloproteinase 13,and cyclooxygenase 2. RESULTS AND CONCLUSION:Patients with osteoarthritis had higher levels of thrombin in the serum compared with normal individuals.Under the microscope,celecoxib was found to significantly inhibit fibroid changes in chondrocytes.Compared with the thrombin group,celecoxib inhibited the proliferation of chondrocytes.The downregulation of extracellular matrix gene expression,such as type II collagen α1,in the thrombin group was inhibited by celecoxib(P<0.05).Thrombin promoted the expression of inflammatory factors(interleukin-1,interleukin-6,and tumor necrosis factor-α),chemokines(monocyte chemotactic protein 2,monocyte chemotactic protein 7,granulocyte chemotactic protein 6),as well as catabolic genes(matrix metalloproteinase 9,matrix metalloproteinase 13,and cyclooxygenase 2),and under the intervention of celecoxib,the expression of these genes could be downregulated(P<0.05).Overall,these findings indicate that celecoxib inhibits the pro-inflammatory effects of thrombin and thereby ameliorates chondrocyte degeneration in rats.
3.Research progress in assisting in the diagnosis of early Alzheimer's disease through eye structure
Xuan HAN ; Jinyan WANG ; Qi ZHOU ; Xiaojuan SU ; Xingyu GUO ; Chunmeng LIU ; Jie CHEN ; Hejiang YE
International Eye Science 2024;24(1):77-81
Alzheimer's disease(AD)is a common degenerative disease of the central nervous system in which neuropathological changes precede cognitive dysfunction and behavioral impairment. Currently, early diagnosis of AD is based on invasive and expensive testing techniques that are difficult to use widely in the clinical setting. Therefore, there is an urgent need for new markers to detect AD at an early stage. The eye, as an extension of the brain, has been found to show earlier onset of ocular pathologic changes in patients with AD compared to brain pathologic changes, such as retinal structural abnormalities, visual dysfunction, retinal abnormal protein accumulation, choroidal thickness changes, decreased corneal nerve fiber density, deposition of abnormal Aβ proteins in the lens, and pupillary light decreased sensitivity of response, etc. This article reviews the ocular pathologic changes in AD patients in recent years to provide new ideas for the early clinical diagnosis of AD.
4.Relationship between coagulation indicators and early stage prognosis in patients with acute respiratory distress syndrome
Xiaoer JIN ; Yufan PU ; Miao WANG ; Chunmeng XUE ; Qingbo LIAO ; Qi DING
Chongqing Medicine 2024;53(15):2296-2300,2307
Objective To investigate the relationship between coagulation indicators and early prognosis in patients with acute respiratory distress syndrome (ARDS).Methods The data of ARDS patients receiving the treatment in the intensive care unit (ICU) from 2008-2019 were selected from the Critical Care Medicine Open Database (MIMIC-Ⅳ V2.0 version) jointly published by MIT,Beth Israel Deaconess Medical Center,and Philips Medical,the data were categorized according to the severity of the patients' disease and the causes of lung damage.The coagulation indexes and 28 d mortality (m28d) rates were compared among different ARDS patients.The receiver operating characteristic (ROC) curve was drawn.The area under the curve was calculated to evaluate the predictive values of the related indicators.The univariate and multivariate logistic re-gression was adopted to analyze the risk factors affecting m28d in the patients with ARDS.Results Maximum prothrombin time (PTmax) in the patients with pulmonary origin ARDS was significantly lower than that in the patients without pulmonary origin ARDS,and the difference was statistically significant (P<0.05).PLTmin,PLTmax and Sequential Organ Failure Assessment (SOFA) score had statistical difference among dif-ferent severity degrees of ARDS patients (P<0.05).Minimum international normalized ratio (INRmin),maxi-mum international normalized ratio (INRmax),minimum prothrombin time (PTmin),PTmax,maximum activated partial thromboplastin time (APTTmax) and SOFA score had statistical differences between the survival group and death group (P<0.05).AUC of INRmin,INRmax,PTmin,PTmax and APTTmax were 0.607,0.624,0.610,0.620 and 0.648 respectively.The multivariate logistic regression analysis showed that APTTmax (OR=1.011,95%CI:1.001-1.022,P=0.029) was an independent risk factor for affecting m28d in the ARDS patients.Conclu-sion Plasma PLT levels in different severities of ARDS patients have the difference and APTTmax on the first day in ICU is an independent risk factor for affecting early prognosis in ARDS patients.
5.Summary of evidence on the management of enteral tube feeding tolerance in postoperative patients with gastric cancer
Jianjian WEI ; Hongxia YAN ; Yue ZHANG ; Chunmeng WANG ; Fang HE
Chinese Journal of Clinical Nutrition 2024;32(6):347-353,363
Objective:To summarize the best evidence of the management of enteral nutrition feeding intolerance (EFI) in postoperative patients with gastric cancer, in order to facilitate the best evidence-based clinical practice.Methods:According to the "6S" evidence pyramid model, relevant guide websites, evidence-based databases, relevant society websites and original literature databases at home and abroad were systematically searched for relevant literature on postoperative tube feeding EFI for gastric cancer patients, and the search time was from the establishment of the database to July 29, 2023. The quality assessment was conducted by two researchers by using AGREE II for guidelines, JBI evidence-based health care center evaluate standards for systematic review and expert consensus.Results:An initial searching of 994 literatures resulted in 23 literatures that met inclusion criteria. Finally, a total of 21 pieces of evidence were summarized from 5 aspects including basic requirements, assessment, interventions, notes and health education.Conclusions:This study summarized the best evidence of management of tube EFI in postoperative gastric cancer patients. Clinical staff should transfer and apply these evidences based on the actual clinical situation, demands, patients' condition of disease and treatment and their preferences, tto reduce the incidence of postoperative tube feeding EFI in patients with gastric cancer.
6.Summary of evidence on the management of enteral tube feeding tolerance in postoperative patients with gastric cancer
Jianjian WEI ; Hongxia YAN ; Yue ZHANG ; Chunmeng WANG ; Fang HE
Chinese Journal of Clinical Nutrition 2024;32(6):347-353,363
Objective:To summarize the best evidence of the management of enteral nutrition feeding intolerance (EFI) in postoperative patients with gastric cancer, in order to facilitate the best evidence-based clinical practice.Methods:According to the "6S" evidence pyramid model, relevant guide websites, evidence-based databases, relevant society websites and original literature databases at home and abroad were systematically searched for relevant literature on postoperative tube feeding EFI for gastric cancer patients, and the search time was from the establishment of the database to July 29, 2023. The quality assessment was conducted by two researchers by using AGREE II for guidelines, JBI evidence-based health care center evaluate standards for systematic review and expert consensus.Results:An initial searching of 994 literatures resulted in 23 literatures that met inclusion criteria. Finally, a total of 21 pieces of evidence were summarized from 5 aspects including basic requirements, assessment, interventions, notes and health education.Conclusions:This study summarized the best evidence of management of tube EFI in postoperative gastric cancer patients. Clinical staff should transfer and apply these evidences based on the actual clinical situation, demands, patients' condition of disease and treatment and their preferences, tto reduce the incidence of postoperative tube feeding EFI in patients with gastric cancer.
7.Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study
Xin LIU ; Chengcheng GONG ; Jieyun ZHANG ; Wanjing FENG ; Yanjing GUO ; Youzhou SANG ; Chunmeng WANG ; Yong CHEN ; Jian WANG ; Lin YU ; Xiaowei ZHANG ; Zhiguo LUO
Cancer Research and Treatment 2023;55(3):1001-1010
Purpose:
Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal malignancy that occurs primarily in children and adolescents. The clinical and pathological features of IMT in adult patients are not well understood.
Materials and Methods:
We retrospectively searched for records of adult patients with IMT at Fudan University Shanghai Cancer Center from 2006 to 2021. Clinicopathological data, treatments, and outcomes were collected and analyzed.
Results:
Thirty adult patients with IMT, mostly women (60.0%), were included. The median age of the patients was 38 (21-77). The most common primary site was abdominopelvic region (53.3%), followed by lungs (20.0%). Seven patients had an abdominal epithelioid inflammatory myofibroblast sarcoma (EIMS). The positivity rate of anaplastic lymphoma kinase (ALK) was 81.5% (22/27). Sixteen patients with advanced ALK-positive disease received crizotinib, with an objective response rate (ORR) of 81.3% and a disease control rate of 87.5%. The median progression-free survival was 20.8 months. EIMS was associated with more aggressive behavior; however, the prognosis was similar to that of non-EIMS patients after treatment with an ALK inhibitor. At a median follow-up time of 30 months (95% confidence interval [CI], 13.6 to 46.4), the 5-year overall survival was 77% (95% CI, 66 to 88) in all patients.
Conclusion
Adult IMTs appeared more aggressive, with a higher incidence of recurrence and metastases, and patients with EIMS had more aggressive cases. Treatment with ALK inhibitors resulted in a high ORR and a durable response, which suggested that ALK inhibitors could be used as a first-line treatment option in adult patients with ALK-positive advanced IMT.
8.jptsd123
WANG Chunmeng ; HONG Lihua ; WANG Yu ; ZHANG Zhimin
Journal of Prevention and Treatment for Stomatological Diseases 2020;28(3):195-199
Esophageal cancer is one of the most lethal digestive system cancers, and its pathogenic factors have always been the focus of research. Recently, it has been found that microorganisms and their metabolites in the esophagus may also represent one of the pathogenic factors. Because of their continuity in anatomical structure, the oral cavity and esophagus have a certain correlation in terms of the composition of flora. In recent years, many scholars have studied the relationship between oral microorganisms and esophageal cancer to monitor changes in oral microorganisms as well as to diagnose and treat esophageal cancer more effectively. In this paper, the research status of oral microorganisms and esophageal cancer was reviewed. The Results of the literature review show that the diversity of bacteria in the esophagus is affected by oral flora in terms of the occurrence and development of esophageal cancer. Among these bacteria, the periodontal red complex, which includes Porphyromonas gingivalis, forsythia and Treponema dentata, as well as common oral microorganisms, such as Streptococcus viridis and Fusobacterium nucleatum, are all related to the occurrence and development of esophageal cancer to a certain extent. At present, there are few studies on the mechanism of microorganisms and esophageal cancer, but scholars have found that lipopolysaccharides and endotoxins, the products of Gram-negative bacteria in the esophagus, may participate in the innate immune response of the host, and the relevant mechanism of action needs further study in order to find new targets for monitoring and treatment.
9.Application of information-based teaching in the experimental teaching of nuclear protection medicine
Zelin CHEN ; Xu TAN ; Yibo GAN ; Rong LI ; Chunmeng SHI ; Tao WANG ; Dengqun LIU ; Yunsheng LIU ; Yu WANG
Chinese Journal of Medical Education Research 2019;18(5):475-478
Information-based teaching was applied in the experimental teaching of nuclear protection medicine based on its own features.The teaching content was sent to students as micro-video via an information platform before class for preview;during the class,the teaching was performed in the form of lectures by students and experiments in groups;after class,students were required to submit reports of experimental improvement or innovative experimental design.A comprehensive assessment was performed for preview,classroom operation,question answering in class,and experimental reports.The results of teaching practice showed that this teaching mode can effectively stimulate the students' interests in learning,enhance their research and innovation abilities,and improve the experimental teaching effect of nuclear protection medicine.
10.Enhanced autophagy protects hepatic cells from radiation injury
Lang LIU ; Dengqun LIU ; Yu WANG ; Ziwen WANG ; Zelin CHEN ; Jie CHEN ; Xiao HAN ; Zujuan LIU ; Aihua ZHANG ; Chunmeng SHI
Chinese Journal of Radiological Medicine and Protection 2018;38(5):335-343
Objective To study the influence of radiation on autophagy and its protective effect on radiation injury of hepatic cells.Methods Autophagy in mouse liver tissues was examined by GFP-LC3 staining and Western blot.Radiation-induced hepatic injury was evaluated by ALT and AST in mouse serum,protein expressions,and H & E and TUNEL staining of liver tissue.L02 cells were used for in vitro study.Chloroquine and rapamycin were used to manipulate the level of autophagy.Results Total body irradiation (TBI) of 8 Gy caused an increase of autophagy in mouse liver tissue and AST level in serum (t =-7.47,P <0.05) at 12 h after irradiation.Irradiation significantly increased the apoptotic level in liver tissue as well.Inhibition of autophagy by chloroquine caused a further increases of AST [IR:(345.42±35.25)U/L vs.IR +CQ:(433.42 ±40.07)U/L,t =-2.86,P<0.05] and ALT [IR:(35.67 ± 8.08) U/L vs.IR+CQ:(98.5±26.67)U/L,t=-3.09,P<0.05] in the serum,and it also promoted apoptosis in live tissue.However,rapamycin as an autophagy promoter showed protective effect for radiation-induced hepatic injury [AST:IR:(345.42 ± 35.25) U/L vs.IR + Rap:(278.42 ± 20.09)U/L,t =-2.86,P < 0.05].Similar changes of autophagy and apoptosis in L02 cells were also observed in the cells treated with chloroquine and rapamycin.Inhibition of autophagy by CQ caused an increase of ROS in vitro and in vivo and further increased ALT and AST levels in serum,reduced L02 cell viability.Activation of autophagy by Rap effectively reversed those changes.Conclusions Autophagy protects hepatic cells from radiation injury by decreasing ROS induction,which provides a potential target for the development of new clinical regimens against radiation induced liver injury.


Result Analysis
Print
Save
E-mail